Innovation With Speed
Reistone Biopharma is focused on the research and development of innovative medicines through global collaborations with sense of urgency.

Patient Need Is Our Passion

Research & Development
At Reistone, we devise our clinical research and development strategy around three key pillars: science, patient and market. These key pillars serve as our guiding principles in medicine development.

Learn more

Media
2021-02-04 Positive Phase 2 Results for Reistone’s JAK Inhibitor Demonstrate Significant Improvement in Patients with Moderate-to-Severe Ulcerative Colitis
2020-10-27 Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis

Learn more

Business Development
Partnership is core to our business model. We are committed to partnering with R&D based global pharma and biotech companies to bring innovative medicines to patients.

Learn more

Career
People represent our key success pillar. We are keen to recruit new talent into Reistone where you can develop and achieve your career aspirations.

Learn more
Shanghai (Headquarter),China
Room 203, 2F, Xiangke Road,
Zhangjiang Hi-Tech Park,
Pudong,Shanghai,China,201210

Beijing,China
Room 101, 4F, Air China Century Building,
No.40 Xiaoyun Road,
Chaoyang District,Beijing, China,100027

Boston,US
#29-126,29th Floor,
1 Lincoln Street,
Massachusetts,USA,MA 02111